Ring Christine, CLO, reported a transaction classified as grant at Nurix Therapeutics, Inc. involving 93750.000000 shares for an estimated $0.00. Reported holdings after the transaction were 93750.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Legal Officer
The stock option vests as to 1/36 of the total shares monthly beginning March 10, 2026, until the option is fully vested on February 9, 2029, subject to the Reporting Person's provision of service to…
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the…
RSUs do not expire; they either vest or are canceled prior to the vest date.
0 other filings
0 recent txs